ACHV

Achieve Life Sciences Inc.

Price

$8.52

return (12m)

231.52%

p/e

-6.03

p/bv

-46.81

DIVIDEND YIELD

0.00%

ACHV price

Achieve Life Sciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ACHV

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

32.50%

3 months

85.22%

1 year

231.52%

2 years

84.02%

5 years

17.68%

10 years

-99.33%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ACHV

Valuation

P/E

-6.03

Sector -4.38

Industry -4.38

P/BV

-46.81

Sector 2.02

Industry 2.02

P/Revenue (PSR)

Sector -4.40

Industry -4.40

EV/EBITDA

-6.82

Sector -263.09

Industry -263.09

EV/EBIT

-6.81

Sector -702.90

Industry -702.90

P/EBITDA

-6.09

Sector -4.39

Industry -4.39

P/EBIT

-6.08

Sector -4.73

Industry -4.73

P/Total Assets

3.61

Sector 1.49

Industry 1.49

P/Net Current Assets

-40.83

Sector -11.70

Industry -11.70

P/Working Capital

-73.33

Sector -3.19

Industry -3.19

EPS

-1.21

Sector -2.14

Industry -2.14

BVPS

-0.16

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

0.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

0.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

0.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

776.84%

Sector -65.14%

Industry -65.14%

ROA

-59.88%

Sector -65.53%

Industry -65.53%

ROIC

-71.02%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

0.95

Sector 2.90

Industry 2.90

Net Debt / EBITDA

2.42

Sector -6.07

Industry -6.07

Net Debt / EBIT

2.41

Sector -8.26

Industry -8.26

Net Debt / Equity

12.25

Sector -1.07

Industry -1.07

Gross Debt / Equity

-0.51

Sector -0.05

Industry -0.05

Equity/Assets

-0.08

Sector 0.41

Industry 0.41

Liabilities/Assets

1.08

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

28.03%

Sector -

Industry -

Fundamentals ACHV

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ACHV Achieve Life Sciences Inc.	$8.52	231.52%	0.00%	-6.03	-46.81	776.84%	0.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ACHV Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Achieve Life Sciences

Achieve Life Sciences Inc.

Average Investor10 user rating

4.0 (3 people)

United States

35 years

Founded: 1991

1995

Time since IPO - 31 years

13

Employees

Achieve Life Sciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $687.14 million, with shareholders equity totaling $-14.68 million.

The company employs approximately 13 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Achieve Life Sciences Inc. reported $- in revenue, generating net income of $-114.04 million.

Key financial metrics include a P/E ratio of -6.03, a price-to-book (P/B) ratio of -46.81, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ACHV.

Market cap

$687.14 million

Net worth

$-14.68 million

$-14,680,000.00

Assets

$190.44 million

$190,440,000.00

Total Shares Outstanding

94.00 million

94,000,000

Average Daily Trading Volume

$1.91 million

$1,910,000.00

Sector

Health Care

Industry

Biotechnology

ACHV

ACHV revenue and profits

Financial Results ACHV

DRAG THE FRAME TO SEE MORE DATA

ACHV cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Achieve Life Sciences (ACHV) today?

A cotação de Achieve Life Sciences (ACHV) hoje está em US$ 8.52, com uma variação de 231.52% em relação ao último ano. A cotação de Achieve Life Sciences (ACHV) iniciou o ano negociando na casa dos US$ 4.97 e hoje está em US$ 8.52. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Achieve Life Sciences (ACHV) e dados de ações do Ibovespa e mercados internacionais.

Quando Achieve Life Sciences (ACHV) paga dividendos?

Achieve Life Sciences (ACHV) não distribuiu dividendos no último ano.

Is Achieve Life Sciences (ACHV) a good investment?

Atualmente, Achieve Life Sciences (ACHV) está cotada a US$ 8.52, com um P/L de -6.03, representando um desvio de -351% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 231.52 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 231.52%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Achieve Life Sciences (ACHV) stock?

Investir em ações de Achieve Life Sciences (ACHV) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Achieve Life Sciences (ACHV) yield today?

A rentabilidade de Achieve Life Sciences (ACHV) foi de 32.50% no último mês, 231.52% no último ano e 17.68% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Achieve Life Sciences (ACHV) hoje, o investimento total seria de US$ 852.00, com base na cotação atual de US$ 8.52.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 2,824.55
Em 5 anos: US$ 1,002.63
Em 10 anos: US$ 5.71

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ACHV

Achieve Life Sciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ACHV

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ACHV WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Achieve Life Sciences

Achieve Life Sciences Inc.

United States

35 years

1995

13

PROFIT X PRICE ACHV

Financial Results ACHV

ACHV cash flow

Asset, Revenue and Profit Growth - ACHV

ACHV balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions